TAVR Assist+ was built to capture patient measurements and perform other straightforward tasks. This gives cardiologists more time to make critical treatment decisions.

The Acticor Sky CRT-DX, which secured FDA approval in April, has officially made its debut in the United States.

MRI scans have traditionally been used for extracellular volume assessments. That is starting to change, however, as cardiac CT moves beyond its typical focus on the coronary arteries.

Ohio-based Riverain Technologies is now making its FDA-cleared suite of AI tools available through RapidAI’s Rapid Enterprise Platform.

For hospitals, health systems and physician groups, effective cardiovascular strategic planning is the foundation for better cardiovascular care delivery, stronger service line performance and sustainable program growth. This article offers a practical approach for cardiovascular leaders who want a service line strategy that is more than a document.

The Chicago-based imaging systems manufacturer will pay the purchase price in cash, acquiring the company from private equity firm Trilantic North America. 

The AHA recognized more than 2,700 U.S. healthcare organizations for managing patients with high blood pressure, high cholesterol and/or type 2 diabetes. 

CMS just finalized major updates to its TAVR coverage policies. Could even more change be on the horizon? 

Orforglipron was linked to consistent weight loss in addition to reductions in waist circumference, systolic blood pressure, triglycerides, non-HDL cholesterol and high-sensitivity C-reactive protein. In terms of safety, it was found to be noninferior to insulin glargine.

Heart failure patients with a CardioMEMS implant can now monitor their own pulmonary artery pressure readings and receive clinician feedback through a smartphone app.